Proactive Investors - Run By Investors For Investors

Genedrive chief operating officer Allan Brown to step down

Genedrive's COO is stepping down after three years in the role
Genedrive is making changes to its management structure

Genedrive PLC (LON:GDR) said chief operating officer Allan Brown is to leave the company.

Brown will step down after 31 January 2018 to ensure a smooth handover, the company said.

"Allan joined the company in 2014 and has played a key role in the development of the genedrive instrument and tests," said non-executive chairman, Ian Gilham.

"On behalf of the board I'd like to thank Allan for his contributions and wish him the very best in his future plans."

The announcement comes a month after the company’s full year results, which revealed a 13.7% rise in turnover thanks to a rise in development income and improved services income.

READ: Genedrive highlights improved turnover as it releases first full year results since reboot

View full GDR profile View Profile

Genedrive PLC Timeline

Related Articles

mri scanner
September 12 2018
IXICO is actively supporting the hunt for breakthrough treatments for Alzheimer’s, Parkinson’s, Huntington’s and multiple sclerosis
June 27 2018
Lancor Scientific is aiming to carry out an initial coin offering by issuing Medici, a new currency based on Ethereum to help Tumour Trace to fund further development
scientist in lab
September 07 2018
Normally, patients have to wait until regulators have approved a drug before they get access to it, but up to 500 lupus sufferers will receive Lupuzor as part of a Managed Access Programme

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use